Sam Chi

Sam Chi is an accomplished professional with extensive experience in commercial strategy and product management within the pharmaceutical industry. Currently serving as Vice President of Commercial and Portfolio Planning at Evommune, Sam previously held roles as Vice President and Executive Director at Global Blood Therapeutics, where responsibilities included leading molecule strategy and lifecycle management for the Oxbryta program. Other notable positions include Senior Director of Strategic Marketing at Dermira, Inc., and various managerial roles at Genentech, Vivus Inc., Human Genome Sciences, and Johnson & Johnson. Sam's academic credentials include an MBA in Marketing and Finance from Duke University's Fuqua School of Business, an MS in Physical Therapy from Columbia University, and a BA in Biology from Boston University.